Fundamental Analysis of SI-BONE INC(NASDAQ:SIBN) stock

Fundamental Rating

Overall SIBN gets a fundamental rating of 3 out of 10. We evaluated SIBN against 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of SIBN is average, but there are quite some concerns on its profitability. SIBN is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SIBN has reported negative net income.

SIBN had a negative operating cash flow in the past year.

SIBN had negative earnings in each of the past 5 years.

In the past 5 years SIBN always reported negative operating cash flow.

1.2 Ratios

SIBN has a Return On Assets of -18.25%. This is comparable to the rest of the industry: SIBN outperforms 52.94% of its industry peers.

Looking at the Return On Equity, with a value of -24.80%, SIBN is in line with its industry, outperforming 58.29% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-18.25%
ROE	-24.8%
ROIC	N/A

ROA(3y)-29.14%

ROA(5y)-27.96%

ROE(3y)-43.35%

ROE(5y)-43.36%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 77.69%, SIBN belongs to the top of the industry, outperforming 91.98% of the companies in the same industry.

In the last couple of years the Gross Margin of SIBN has declined.

SIBN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	77.69%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.57%

GM growth 5Y-2.87%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SIBN does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, SIBN has more shares outstanding

SIBN has more shares outstanding than it did 5 years ago.

The debt/assets ratio for SIBN has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 5.07 indicates that SIBN is not in any danger for bankruptcy at the moment.

SIBN has a Altman-Z score of 5.07. This is in the better half of the industry: SIBN outperforms 76.47% of its industry peers.

A Debt/Equity ratio of 0.22 indicates that SIBN is not too dependend on debt financing.

The Debt to Equity ratio of SIBN (0.22) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	N/A
Altman-Z	5.07

ROIC/WACCN/A

WACC8.85%

2.3 Liquidity

A Current Ratio of 9.17 indicates that SIBN has no problem at all paying its short term obligations.

SIBN has a better Current ratio (9.17) than 90.37% of its industry peers.

A Quick Ratio of 8.12 indicates that SIBN has no problem at all paying its short term obligations.

SIBN has a better Quick ratio (8.12) than 90.91% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	9.17
Quick Ratio	8.12

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SIBN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.19%, which is quite impressive.

The Revenue has grown by 21.15% in the past year. This is a very strong growth!

The Revenue has been growing by 20.18% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)25.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%26.67%

Revenue 1Y (TTM)21.15%

Revenue growth 3Y23.69%

Revenue growth 5Y20.18%

Sales Q2Q%20.01%

3.2 Future

SIBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.09% yearly.

The Revenue is expected to grow by 18.41% on average over the next years. This is quite good.

EPS Next Y19.94%

EPS Next 2Y15.23%

EPS Next 3Y15.09%

EPS Next 5YN/A

Revenue Next Year21.04%

Revenue Next 2Y19.17%

Revenue Next 3Y18.41%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SIBN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year SIBN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as SIBN's earnings are expected to grow with 15.09% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y15.23%

EPS Next 3Y15.09%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for SIBN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SI-BONE INC

NASDAQ:SIBN (11/12/2024, 8:00:02 PM)

After market: 11.5 -4.13 (-26.42%)

15.63

-0.29 (-1.82%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap651.61M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-18.25%
ROE	-24.8%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	77.69%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.67

Health

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	9.17
Quick Ratio	8.12
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)25.19%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y19.94%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)21.15%

Revenue growth 3Y23.69%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

SI-BONE INC (SIBN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens